EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression



Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression



Transplantation Proceedings 32(7): 2543-2543




(PDF same-day service: $19.90)

Accession: 047237222

Download citation: RISBibTeXText

PMID: 11120285

DOI: 10.1016/s0041-1345(00)01783-8



Related references

Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function. Transplantation Proceedings 35(1): 87-88, 2003

Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. Transplantation Proceedings 37(7): 3009-3011, 2005

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial. Liver Transplantation 11(9): 1064-1072, 2005

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. Transplantation 65(2): 248-252, 1998

Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients. Transplantation Proceedings 36(7): 2084-2086, 2004

Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. Transplantation Proceedings 31(7a): 75s-77s, 1999

Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. Transplantation Proceedings 40(3): 705-707, 2008

Corticosteroid minimization in pediatric renal transplant recipients under thymoglobulin, tacrolimus and mycophenolate mofetil immunosuppression. Journal of the American Society of Nephrology 14(Abstracts Issue): 647A, November, 2003

Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. Transplantation Proceedings 34(4): 1265-1268, 2002

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. Transplantation 73(7): 1100-1106, 2002

Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. Transplantation Proceedings 33(1-2): 1013-1014, 2001

A prospective randomized open study in liver transplant recipients: daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids. Liver Transplantation 15(11): 1542-1552, 2010

The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants. Clinical Transplantation 15(2): 142-145, 2001

Randomized multicenter trial comparing tacrolimus plus mycophenolate mofetil with tacrolimus plus steroids among HCV-positive recipients of living donor liver transplantation. 2013

De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. Transplantation Proceedings 37(5): 2231-2239, 2005